RxDoctor Payments DataLook up a doctor →

Christopher Kwolek, MD

Vascular Surgery · Boston, MANPI 1689665309

Payments from drug & device makers

$457,338in general payments, 2019–2025

Across 301 payments — averaging $1519.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Veryan Medical Incorporated$282K
  • Endologix LLC$72K
  • Silk Road Medical, Inc.$44K
  • W. L. Gore & Associates, Inc.$36K
  • Philips North America LLC$15K
  • Cordis US CORP.$3K
  • plus $7K from 32 others
$12,752in research payments, 2019–2025

Across 1 payment — averaging $12,752 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Veryan Medical Incorporated$13K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$457,338 in reported general payments places this provider in the 95th percentile of 142 vascular surgery providers in Massachusetts.

See all vascular surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$700,314
Medicare patients
421
Services billed
1,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →